Literature DB >> 23830732

CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women.

Priyanka Gokhale1, Shilpa Kerkar, Hemant Tongaonkar, Vinita Salvi, Jayanti Mania-Pramanik.   

Abstract

Single nucleotide polymorphisms (SNPs) in the CTLA-4 gene exert differential effects on T-cell response to viral infection. We aimed to evaluate the association of two SNPs of the CTLA-4 gene with cervical cancer in Indian women. The two polymorphic loci, one in the promoter region -318 C>T, rs5742909 (100 cervical cancer cases and 101 controls) and the other in exon 1 +49 A>G, rs231775 (104 cervical cancer cases and 162 controls) were genotyped using polymerase chain reaction-restriction fragment length polymorphism methods. Haplotype block structure was determined using Haploview 4.2. The statistical analyses were performed using a commercially available statistical software package, whereas PyPop was used to calculate the haplotypic frequencies. In this case-control study, the A/A genotype frequency (30.76% vs. 17.6%, P = 0.01) as well as the allelic frequency for A (52.8% vs. 43.5%, P = 0.04) was significantly higher in cases compared to controls. No significant association was seen in the -318 C>T polymorphism. In forward stepwise binary logistic regression analysis considering age and parity as potential confounders, significant association was demonstrated between +49 A/A and cervical cancer. Most likely, this is the first study from India to highlight the significant association between the CTLA-4 gene +49 A/A SNP and cervical cancer, thus adding to the global knowledge of the association of this SNP with cervical cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTLA-4; HPV; India; cervical cancer

Mesh:

Substances:

Year:  2013        PMID: 23830732     DOI: 10.1016/j.cancergen.2013.04.003

Source DB:  PubMed          Journal:  Cancer Genet


  11 in total

1.  Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.

Authors:  Lei Wang; Guixiang Su; Xinghua Zhao; Yi Cai; Xianan Cai; Jie Zhang; Jian Liu; Tongqing Wang; Jizheng Wang
Journal:  Tumour Biol       Date:  2013-09-08

Review 2.  The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.

Authors:  Ping Liu; Li Xu; Yuan Sun; Zhiping Wang
Journal:  Tumour Biol       Date:  2013-12-10

3.  Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.

Authors:  Shabnam Abtahi; Fatemeh Izadi Jahromi; Mohammad Hossein Dabbaghmanesh; Mahyar Malekzadeh; Abbas Ghaderi
Journal:  Endocrine       Date:  2018-08-04       Impact factor: 3.633

4.  Association between the cytotoxic T-lymphocyte antigen 4-318C/T polymorphism and malignant tumor risk.

Authors:  Taiming Li; Chengdi Wang; Zhenju Ren; Y I Ji; Chang Xu; Bing Xiao; Min Liu
Journal:  Biomed Rep       Date:  2016-05-19

5.  Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.

Authors:  Lu Wang; Zhiwei Jiang; Hao Qiu; Weifeng Tang; Tanghai Duan; Lixin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.

Authors:  Rui Geng; Fanglong Song; Xiao Yang; Peng Sun; Junzheng Hu; Chunhui Zhu; Binjie Zhu; Weimin Fan
Journal:  Tumour Biol       Date:  2013-12-05

7.  Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.

Authors:  Changchun Fan; Xuechun Zhao; Zhixing Xu
Journal:  Tumour Biol       Date:  2014-09-18

8.  Ctla-4 gene polymorphism in +49 a/g position: a case control study on patients with oral lichen planus.

Authors:  Jannan Ghapanchi; Mohammad Reza Haghshenas; Hamid Ghaderi; Sara Amanpour; Venus Nemati; Fereshteh Kamali
Journal:  J Int Oral Health       Date:  2014-09

Review 9.  Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.

Authors:  Marta Wagner; Monika Jasek; Lidia Karabon
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

10.  CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.

Authors:  ShiWan Hu; Dan Pu; XueYi Xia; BeiXi Guo; ChuanLi Zhang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.